Visionary Holdings (NASDAQ:GV) shares are under pressure after the company’s 2025 annual report revealed a significant revenue contraction and mounting liquidity concerns.
The Toronto-headquartered firm, which is transitioning from its legacy education and real estate roots toward high-tech health management and anti-aging, reported total revenue of $5.04 million for the fiscal year—a 46.2% decrease year-over-year.
The decline was primarily attributed to a sharp contraction in real estate leasing and a shifting regulatory landscape for its education services.
Despite the top-line drop, management highlighted that its emerging life sciences and health-related businesses contributed $1.06 million, or roughly 21.1% of total revenue, signaling an early-stage validation of its strategic pivot.
The financial picture remains strained, with Visionary reporting a net loss of $15.75 million.
This loss includes $4.70 million in asset impairment charges and one-time costs related to its business transformation.
Most critically, the company disclosed a negative working capital of $54.50 million and ongoing liquidity pressures, leading to negotiations with creditors and efforts to secure new equity financing.